Neurology News

Medical device company WISE Srl announced the FDA granted clearance for its Cortical Strip, a single-use device intended to be used on the brain surface for intraoperative neurophysiological monitoring.

NeuroPace Inc. announced that the first patient with Lennox-Gastaut Syndrome was treated in its investigational device exemption feasibility study, which will evaluate the company’s neuromodulation technology.

Dementia prevalence dropped 3.7 percentage points in the U.S. from 2000 to 2016, according to a RAND Corporation study published in Proceedings of the National Academy of Sciences.

Children who were exposed to Zika virus in utero may demonstrate developmental differences into preschool age, even if they did not have congenital Zika syndrome, according to a study published in Pediatric Research.

Clinical-stage biopharmaceutical company Clene Inc. announced proof-of-concept evidence of potential neuroprotective effects of CNM-Au8, an oral therapeutic for patients with stable relapsing-remitting MS.

The Parkinson’s Foundation and data analytics platform Tag.bio have announced a partnership to advance research into the causes and treatment of Parkinson’s disease.

Childhood poverty was associated with increases in externalizing problems, but not internalizing, over time in early adolescence, researchers reported in JAMA Network Open.

Practices may find this short primer on state pass-through entity election and year-end tax tips helpful to determine whether they can benefit from a state tax strategy or create some tax savings before Jan. 1, 2023.

In this edition, risk factors linked to PD, digital brain health platform offers dementia risk assessment, Klotho protein levels linked to Alzheimer's and more.

Lecanemab reduced amyloid markers and slowed cognitive decline in patients with early Alzheimer’s disease, although not without risk for adverse events, according to new data published in The New England Journal of Medicine.